Search Results - "Perni, R"

Refine Results
  1. 1

    Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease by Lin, C, Kwong, A D, Perni, R B

    Published in Infectious disorders drug targets (01-03-2006)
    “…The hepatitis C virus (HCV) NS3.4A protease, which is essential for viral replication, is considered one of the most attractive targets for developing novel…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Inhibition of Human Hepatitis B Virus Replication by AT-61, a Phenylpropenamide Derivative, Alone and in Combination with (−)β-l-2′,3′-Dideoxy-3′-Thiacytidine by King, R W, Ladner, S K, Miller, T J, Zaifert, K, Perni, R B, Conway, S C, Otto, M J

    Published in Antimicrobial Agents and Chemotherapy (01-12-1998)
    “…ERRATUM ( vol. 43 , p. 726 ) Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
    Get full text
    Journal Article
  4. 4

    Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication by Perni, Robert B, Conway, Samuel C, Ladner, Stephanie K, Zaifert, Katie, Otto, Michael J, King, Robert W

    Published in Bioorganic & medicinal chemistry letters (04-12-2000)
    “…A non-nucleoside class of compounds that inhibits the replication of hepatitis B virus (HBV) in cell culture has been discovered. A series of substituted…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    3-Quinolinecarboxamides. A series of novel orally-active antiherpetic agents by Wentland, Mark P, Perni, Robert B, Dorff, Peter H, Brundage, R. Pauline, Castaldi, Michael J, Bailey, Thomas R, Carabateas, Philip M, Bacon, Edward R, Young, Dorothy C

    Published in Journal of medicinal chemistry (28-05-1993)
    “…A series of novel 3-quinolinecarboxamides that are structurally similar to the quinolone class of antibacterial agents possess excellent antiherpetic…”
    Get full text
    Journal Article
  8. 8

    Circulating miR-126-3p and miR-423-5p Expression in de novo Adult Acute Myeloid Leukemia: Correlations with Response to Induction Therapy and the 2-Year Overall Survival by Almohsen, Faez, Al-Rubaie, Haithem A, Habib, Manal A, Nasr, Sherif A, Perni, Rajendra, Al-Quraishi, Lubab

    Published in Journal of blood medicine (01-01-2022)
    “…Acute myeloid leukemia (AML) results from sequential genetic alterations in a normal hematopoietic stem cell or its progenitors giving rise to an autonomous…”
    Get full text
    Journal Article
  9. 9

    Cyclic Variations of 3-Quinolinecarboxamides and Effects on Antiherpetic Activity by Wentland, Mark P, Carlson, John A, Dorff, Peter H, Aldous, Suzanne C, Perni, Robert B, Young, Dorothy C, Woods, Maureen G, Kingsley, Susan D, Ryan, Kathryn A, Rosi, David, Drozd, Marion L, Dutko, Frank J

    Published in Journal of medicinal chemistry (01-07-1995)
    “…Supported by the antiherpetic properties of 3-quinolinecarboxamides and the importance of the planar intramolecular H-bonded beta-keto amide pharmacophore, a…”
    Get full text
    Journal Article
  10. 10

    Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative by Wentland, Mark P, Perni, Robert B, Dorff, Peter H, Rake, James B

    Published in Journal of medicinal chemistry (01-09-1988)
    “…A novel conformationally restricted 1-cyclopropylquinolone (1) that incorporates structural features of both ofloxacin and ciprofloxacin has been prepared…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: Novel antiarrhythmic agents by Johnson, Robert E, Baizman, Eugene R, Becker, Carolyn, Bohnet, Eric A, Bell, Rebecca H, Birsner, Nancy C, Busacca, Carl A, Carabateas, Philip M, Chadwick, Christopher C

    Published in Journal of medicinal chemistry (29-10-1993)
    “…A series of 4,5-dihydro-1-phenyl-1H-2,4-benzodiazepines has been identified as potential antiarrhythmic agents that interact with sodium and potassium channels…”
    Get full text
    Journal Article
  14. 14
  15. 15

    In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061 by Lin, Chao, Gates, Cynthia A., Rao, B. Govinda, Brennan, Debra L., Fulghum, John R., Luong, Yu-Ping, Frantz, J. Daniel, Lin, Kai, Ma, Sue, Wei, Yun-Yi, Perni, Robert B., Kwong, Ann D.

    Published in The Journal of biological chemistry (04-11-2005)
    “…VX-950 is a potent, small molecule, peptidomimetic inhibitor of the hepatitis C virus (HCV) NS3·4A serine protease and has recently been shown to possess…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin by Corbett, T H, Panchapor, C, Polin, L, Lowichik, N, Pugh, S, White, K, Kushner, J, Meyer, J, Czarnecki, J, Chinnukroh, S, Edelstein, M, LoRusso, P, Heilbrun, L, Horwitz, J P, Grieshaber, C, Perni, R, Wentland, M, Coughlin, S, Elenbaas, S, Philion, R, Rake, J

    Published in Investigational new drugs (01-02-1999)
    “…A highly active and broadly active thioxanthone has been identified: N-[[1-[[2-(Diethylamino)ethyl]amino]-7-methoxy-9-oxo-9H-thioxanthen++ +-4-yl]…”
    Get full text
    Journal Article
  20. 20